Stockreport

Therapix expects to have results of Tourette's drug trial by end of Q1 [Reuters]

THERAPIX BIOSCIENCES LTD AMERICAN DEPOSITARY SHARE  (TRPX) 
US:NASDAQ Investor Relations: nasdaq.com/symbol/trpx
PDF Therapix expects to have results of Tourette's drug trial by end of Q1 | Reuters 3 Min Read TEL AVIV, Dec 4 (Reuters) - Israel’s Therapix Biosciences said on Monday it e [Read more]